Aetna acquires Medicity Today announced that it has completed its acquisition of Medicity Inc Aetna., a ongoing health info exchange technology company, headquartered in Salt Lake Town, Utah. A leading innovator in company solutions, Medicity offers a broad range of services and products that enable health systems, hospitals, physician procedures and health information exchanges to securely gain access to and exchange healthcare information, improving the product quality and performance of patient treatment and reducing unnecessary health care costs.The reductions from baseline in mean every week itch-severity scores were dose-responsive with all three omalizumab dosages and were better than the placebo responses at that time points before week 12 . After week 12 , the mean weekly itch-severity ratings for all omalizumab groups increased to reach values similar to those in the placebo group and didn’t go back to baseline values throughout follow-up. Sensitivity analyses for the primary end point which used different options for handling missing data showed very similar results to those of the principal evaluation . S1 through S6 in the Supplementary Appendix), aside from the difference in the true number of angioedema-free times from week 4 to week 12, which reached significance just in the 300-mg group. Similar to weekly itch-severity scores, the every week score for the amount of hives reduced with all three dosages of omalizumab to a greater extent than with placebo throughout the 12-week treatment period, with the biggest difference seen in the 300-mg group .